Novo Nordisk A/S vs Sony Group Corporation
Market cap comparison over time
Novo Nordisk A/S
$147.3B
Rank #118
Sony Group Corporation
$148.1B
Rank #116
Market Cap Over Time
Key Moments
- Novo Nordisk A/S overtook Sony Group Corporation by 2009
- Sony Group Corporation overtook Novo Nordisk A/S by 2025
Year-by-Year Comparison
| Year | Novo Nordisk A/S | Sony Group Corporation | Leader |
|---|---|---|---|
| 2026 | $147.3B | $148.1B | Sony Group Corporation |
| 2025 | $152.9B | $158.2B | Sony Group Corporation |
| 2024 | $285.3B | $131.7B | Novo Nordisk A/S |
| 2023 | $315.6B | $104.1B | Novo Nordisk A/S |
| 2022 | $209.4B | $77.4B | Novo Nordisk A/S |
| 2021 | $161.6B | $110.9B | Novo Nordisk A/S |
| 2020 | $92.0B | $78.4B | Novo Nordisk A/S |
| 2019 | $81.6B | $56.0B | Novo Nordisk A/S |
| 2018 | $61.4B | $40.0B | Novo Nordisk A/S |
| 2017 | $67.2B | $38.0B | Novo Nordisk A/S |
| 2016 | $49.6B | $24.4B | Novo Nordisk A/S |
| 2015 | $75.8B | $22.2B | Novo Nordisk A/S |
| 2014 | $48.6B | $18.2B | Novo Nordisk A/S |
| 2013 | $36.5B | $13.4B | Novo Nordisk A/S |
| 2012 | $33.0B | $6.9B | Novo Nordisk A/S |
| 2011 | $23.3B | $9.8B | Novo Nordisk A/S |
| 2010 | $43.8B | $20.4B | Novo Nordisk A/S |
| 2009 | $22.7B | $18.5B | Novo Nordisk A/S |
| 2008 | $9.1B | $13.2B | Sony Group Corporation |
| 2007 | $22.1B | $42.0B | Sony Group Corporation |
| 2006 | $7.7B | $34.4B | Sony Group Corporation |
| 2005 | $5.7B | $32.3B | Sony Group Corporation |
| 2004 | $9.4B | $26.4B | Sony Group Corporation |
| 2003 | $7.5B | $24.6B | Sony Group Corporation |
| 2002 | $6.2B | $32.7B | Sony Group Corporation |
| 2001 | $10.3B | $39.3B | Sony Group Corporation |